29Sep
Regulatory Considerations for M&A Investors During COVID-19 - Era 3-Part Series: COVID-19’s Impact on US & Indian M&A Markets
The COVID-19 pandemic and the corresponding economic volatility has dramatically impacted the US and the Indian M&A market. While many high-profile companies have abandoned proposed deals, various other companies have expressed or maintained interest in pursuing strategic acquisitions during this time. This article discusses the regulatory changes that parties should consider when contemplating M&A events in the Indian and the US markets in the wake of COVID-19....
By:
Kilpatrick Townsend & Stockton LLP
Related
H.I.G. BioHealth Partners, the life-science investment affiliate of H.I.G. Capital, has announced th...
Read More >
In this article, we follow up on our overview of going private transactions (available here) by focu...
Read More >
Section 220 of the Delaware General Corporation Law affords stockholders a qualified right to inspec...
Read More >
Holidays parties are common in many law firms. The idea behind the holiday party is almost always no...
Read More >
New York Governor Andrew Cuomo has signed into law a bill which, effective immediately, prohibits em...
Read More >
On November 12, 2020, President Trump issued an Executive Order titled "Addressing the Threat from S...
Read More >